| pubmed-article:19187369 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:19187369 | lifeskim:mentions | umls-concept:C0043210 | lld:lifeskim |
| pubmed-article:19187369 | lifeskim:mentions | umls-concept:C0677886 | lld:lifeskim |
| pubmed-article:19187369 | lifeskim:mentions | umls-concept:C0038952 | lld:lifeskim |
| pubmed-article:19187369 | lifeskim:mentions | umls-concept:C1306673 | lld:lifeskim |
| pubmed-article:19187369 | lifeskim:mentions | umls-concept:C0681842 | lld:lifeskim |
| pubmed-article:19187369 | lifeskim:mentions | umls-concept:C0205179 | lld:lifeskim |
| pubmed-article:19187369 | pubmed:issue | 3 | lld:pubmed |
| pubmed-article:19187369 | pubmed:dateCreated | 2009-2-3 | lld:pubmed |
| pubmed-article:19187369 | pubmed:abstractText | Prognosis in women with ovarian cancer mainly depends on International Federation of Gynecology and Obstetrics stage and the ability to perform optimal cytoreductive surgery. Since ovarian cancer has a heterogeneous presentation and clinical course, predicting progression-free survival (PFS) and overall survival (OS) in the individual patient is difficult. The objective of this study was to determine predictors of PFS and OS in women with advanced stage epithelial ovarian cancer (EOC) after primary cytoreductive surgery and first-line platinum-based chemotherapy. | lld:pubmed |
| pubmed-article:19187369 | pubmed:language | eng | lld:pubmed |
| pubmed-article:19187369 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19187369 | pubmed:citationSubset | AIM | lld:pubmed |
| pubmed-article:19187369 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19187369 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:19187369 | pubmed:month | Feb | lld:pubmed |
| pubmed-article:19187369 | pubmed:issn | 1471-0528 | lld:pubmed |
| pubmed-article:19187369 | pubmed:author | pubmed-author:de JongDD | lld:pubmed |
| pubmed-article:19187369 | pubmed:author | pubmed-author:BurgerC WCW | lld:pubmed |
| pubmed-article:19187369 | pubmed:author | pubmed-author:AnsinkA CAC | lld:pubmed |
| pubmed-article:19187369 | pubmed:author | pubmed-author:HaasB MBM | lld:pubmed |
| pubmed-article:19187369 | pubmed:author | pubmed-author:BaalbergenAA | lld:pubmed |
| pubmed-article:19187369 | pubmed:author | pubmed-author:GeresteinC... | lld:pubmed |
| pubmed-article:19187369 | pubmed:author | pubmed-author:van der... | lld:pubmed |
| pubmed-article:19187369 | pubmed:author | pubmed-author:EijkemansM... | lld:pubmed |
| pubmed-article:19187369 | pubmed:author | pubmed-author:DykgraafR H... | lld:pubmed |
| pubmed-article:19187369 | pubmed:issnType | Electronic | lld:pubmed |
| pubmed-article:19187369 | pubmed:volume | 116 | lld:pubmed |
| pubmed-article:19187369 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:19187369 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:19187369 | pubmed:pagination | 372-80 | lld:pubmed |
| pubmed-article:19187369 | pubmed:meshHeading | pubmed-meshheading:19187369... | lld:pubmed |
| pubmed-article:19187369 | pubmed:meshHeading | pubmed-meshheading:19187369... | lld:pubmed |
| pubmed-article:19187369 | pubmed:meshHeading | pubmed-meshheading:19187369... | lld:pubmed |
| pubmed-article:19187369 | pubmed:meshHeading | pubmed-meshheading:19187369... | lld:pubmed |
| pubmed-article:19187369 | pubmed:meshHeading | pubmed-meshheading:19187369... | lld:pubmed |
| pubmed-article:19187369 | pubmed:meshHeading | pubmed-meshheading:19187369... | lld:pubmed |
| pubmed-article:19187369 | pubmed:meshHeading | pubmed-meshheading:19187369... | lld:pubmed |
| pubmed-article:19187369 | pubmed:meshHeading | pubmed-meshheading:19187369... | lld:pubmed |
| pubmed-article:19187369 | pubmed:meshHeading | pubmed-meshheading:19187369... | lld:pubmed |
| pubmed-article:19187369 | pubmed:meshHeading | pubmed-meshheading:19187369... | lld:pubmed |
| pubmed-article:19187369 | pubmed:meshHeading | pubmed-meshheading:19187369... | lld:pubmed |
| pubmed-article:19187369 | pubmed:meshHeading | pubmed-meshheading:19187369... | lld:pubmed |
| pubmed-article:19187369 | pubmed:meshHeading | pubmed-meshheading:19187369... | lld:pubmed |
| pubmed-article:19187369 | pubmed:meshHeading | pubmed-meshheading:19187369... | lld:pubmed |
| pubmed-article:19187369 | pubmed:meshHeading | pubmed-meshheading:19187369... | lld:pubmed |
| pubmed-article:19187369 | pubmed:meshHeading | pubmed-meshheading:19187369... | lld:pubmed |
| pubmed-article:19187369 | pubmed:meshHeading | pubmed-meshheading:19187369... | lld:pubmed |
| pubmed-article:19187369 | pubmed:meshHeading | pubmed-meshheading:19187369... | lld:pubmed |
| pubmed-article:19187369 | pubmed:year | 2009 | lld:pubmed |
| pubmed-article:19187369 | pubmed:articleTitle | The prediction of progression-free and overall survival in women with an advanced stage of epithelial ovarian carcinoma. | lld:pubmed |
| pubmed-article:19187369 | pubmed:affiliation | Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, Daniel den Hoed/Erasmus MC University Medical Center, Rotterdam, The Netherlands. c.gerestein@erasmusmc.nl | lld:pubmed |
| pubmed-article:19187369 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:19187369 | pubmed:publicationType | Multicenter Study | lld:pubmed |
| pubmed-article:19187369 | pubmed:publicationType | Validation Studies | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:19187369 | lld:pubmed |
